3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Recruiting
1
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Conditions
Ovarian Neoplasms
1
Fallopian Tube Neoplasms
1
Carcinoma, Ovarian Epithelial
1
Interventions
Paclitaxel
10
Carboplatin
6
Bevacizumab
5
pembrolizumab
4
Cyclophosphamide
4
olaparib
3
liposomal doxorubicin
3
fludarabine
3
ribociclib
2
palbociclib
2
mirvetuximab soravtansine
2
Topotecan
2
Nivolumab
2
Letrozole
2
Fulvestrant
2
Blood Specimen Collection
2
trastuzumab deruxtecan
1
sacituzumab govitecan
1
pegfilgrastim
1
niraparib
1
lenvatinib
1
isoquercitrin
1
fludarabine phosphate
1
durvalumab
1
cemiplimab
1
abemaciclib
1
Tinzaparin
1
Surveys and Questionnaires
1
Surgical Procedures, Operative
1
SLC25A33 protein, human
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Recruiting
×
Carcinoma, Ovarian Epithelial
×
GEN-1
×
Clear all
NCT06915025
2026-06-02
OVATION-3
Imunon
Phase 3
Recruiting
500 enrolled